Enhanced Expression of NGF Receptors in Multiple Sclerosis Lesions

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Neuropathology and Experimental Neurology

• Publication date

  2002-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JNEN/61.1.91PMID 11829348
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Surprising Pleiotropy of Nerve Growth Factor in the Treatment of Experimental Autoimmune Encephalomyelitis

  2000cited by this paper
• Human Nerve Growth Factor Protects Common Marmosets against Autoimmune Encephalomyelitis by Switching the Balance of T Helper Cell Type 1 and 2 Cytokines within the Central Nervous System

  2000influential reference
• Glial cells as targets and producers of neurotrophins.

  2000cited by this paper
• Tumor Necrosis Factor α and Human Schwann Cells: Signalling and Phenotype Modulation Without Cell Death

  2000cited by this paper
• NG2-Positive Oligodendrocyte Progenitor Cells in Adult Human Brain and Multiple Sclerosis Lesions

  2000influential reference
• Neurotrophins in cell survival/death decisions.

  1999cited by this paper
• Oligodendrocyte Apoptosis Mediated by Caspase Activation

  1999cited by this paper
• Neurotrophin signaling via Trks and p75.

  1999cited by this paper
• Up-regulated p75NTR neurotrophin receptor on glial cells in MS plaques

  1999influential reference
• Activation of NF-kappaB and c-jun transcription factors in multiple sclerosis lesions. Implications for oligodendrocyte pathology.

  1999cited by this paper
• Altered nerve growth factor level in the optic nerve of patients affected by multiple sclerosis

  1999influential reference
• Transcription Factor NF-kB and Inhibitor kBα are Localized in Macrophages in Active Multiple Sclerosis Lesions

  1998cited by this paper
• p75 Neurotrophin Receptor Expression on Adult Human Oligodendrocytes: Signaling without Cell Death in Response to NGF

  1998influential reference
• Competitive Signaling Between TrkA and p75 Nerve Growth Factor Receptors Determines Cell Survival

  1998cited by this paper
• Nerve Growth Factor Induces Process Formation in Meningeal Cells: Implications for Scar Formation in the Injured CNS

  1998influential reference
• Transcription factor NF-kappaB and inhibitor I kappaBalpha are localized in macrophages in active multiple sclerosis lesions.

  1998cited by this paper
• Low affinity NGF receptor expression in the central nervous system during experimental allergic encephalomyelitis

  1998cited by this paper
• Neurotrophin receptors: mediators of life and death.

  1998cited by this paper
• Changes of NGF presence in nonneuronal cells in response to experimental allergic encephalomyelitis in Lewis rats.

  1998cited by this paper
• Multiple sclerosis: Oligodendrocytes display cell death–related molecules in situ but do not undergo apoptosis

  1997cited by this paper
• Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75

  1996cited by this paper
• Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75.

  1996cited by this paper
• Selective Activation of NF-κB by Nerve Growth Factor Through the Neurotrophin Receptor p75

  1996cited by this paper
• Multiple Sclerosis: Fas Signaling in Oligodendrocyte Cell Death

  1996cited by this paper
• mRNA for NGF and p75 in the central nervous system of rats affected by experimental allergic encephalomyelitis

  1996influential reference
• In vitro glial responses to nerve growth factor

  1995cited by this paper
• Co-expression of mRNA for Neurotrophic Factors in Human Neurons and Glial Cells in Culture

  1994cited by this paper
• Nerve growth factor production by lymphocytes.

  1994cited by this paper
• CNS glial cells express neurotrophin receptors whose levels are regulated by NGF.

  1993cited by this paper
• Induction of apoptosis by the low-affinity NGF receptor.

  1993cited by this paper
• Expression of nerve growth factor receptor in human peripheral neuropathies

  1988cited by this paper
• Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies.

  1984cited by this paper
• DEMYELINATING diseases.

  1952cited by this paper

• Synthetic microneurotrophins: Neurotrophin receptors for therapeutics of neurodegenerative diseases

  2025cites this paper
• Delivery of Neuroregenerative Proteins to the Brain for Treatments of Neurodegenerative Brain Diseases

  2024cites this paper
• Nerve Growth Factor and Autoimmune Diseases

  2023cites this paper
• The adaptation model of immunity: A new insight into aetiology and treatment of multiple sclerosis

  2023cites this paper
• Topical delivery of nerve growth factor for treatment of ocular and brain disorders

  2021cites this paper
• Listening to the Whispers in Neuroimmune Crosstalk: A Comprehensive Workflow to Investigate Neurotrophin Receptor p75NTR Under Endogenous, Low Abundance Conditions

  2021cites this paper
• Spatio-temporal expression profile of NGF and the two-receptor system, TrkA and p75NTR, in experimental autoimmune encephalomyelitis

  2020cites this paper
• Nerve growth factor is elevated in the CSF of patients with multiple sclerosis and central neuropathic pain.

  2018cites this paper
• Dynamic Changes in Brain Mesenchymal Perivascular Cells Associate with Multiple Sclerosis Disease Duration, Active Inflammation, and Demyelination

  2017cites this paper
• The novel synthetic microneurotrophin BNN27 protects mature oligodendrocytes against cuprizone‐induced death, through the NGF receptor TrkA

  2017cites this paper
• Tibial Nerve Stimulation for the management of overactive bladder and the measurement of urinary neurotrophins as a biomarker of response to treatment

  2017cites this paper
• No quiet surrender: molecular guardians in multiple sclerosis brain.

  2015cites this paper
• Immune System Induction of Nerve Growth Factor in an Animal Model of Multiple Sclerosis: Implications in Re-Myelination and Myelin Repair.

  2015cites this paper
• Affinity proteomic profiling of plasma, cerebrospinal fluid, and brain tissue within multiple sclerosis.

  2014cites this paper
• Receptor Tyrosine Kinase and Tyrosine Kinase Inhibitors: New Hope for Success in Multiple Sclerosis Therapy.

  2014cites this paper
• Type I interferons up-regulate the expression and signalling of p75 NTR/TrkA receptor complex in differentiated human SH-SY5Y neuroblastoma cells.

  2014cites this paper
• A novel in vitro human microglia model: characterization of human monocyte-derived microglia.

  2012cites this paper
• Tyrosine Kinase Inhibitors Ameliorate Autoimmune Encephalomyelitis in a Mouse Model of Multiple Sclerosis

  2011cites this paper
• Emerging functions of myelin‐associated proteins during development, neuronal plasticity, and neurodegeneration

  2011cites this paper
• Zytokinmuster unter Fitnesstraining bei MS-Patienten und Gesunden

  2009cites this paper
• Oligodendroglial Cells and Neurotrophins: A Polyphonic Cantata in Major and Minor

  2008cites this paper
• Neurotrophic Factors in Neurodegenerative Disorders

  2008cites this paper
• Transketolase and 2′,3′-Cyclic-nucleotide 3′-Phosphodiesterase Type I Isoforms Are Specifically Recognized by IgG Autoantibodies in Multiple Sclerosis Patients *S

  2008cites this paper
• Novel autoantigens recognized by CSF IgG from Hashimoto's encephalitis revealed by a proteomic approach.

  2008cites this paper
• NGF promotes microglial migration through the activation of its high affinity receptor: modulation by TGF-beta.

  2007cites this paper
• Anti-GD2-like IgM autoreactivity in multiple sclerosis patients

  2006cites this paper
• An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis.

  2005cites this paper
• Nogo-A and Nogo Receptor Expression in Demyelinating Lesions of Multiple Sclerosis

  2005cites this paper
• Basal plasma levels and reactivity of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) to standardized acute exercise in multiple sclerosis and controls

  2005influential citation
• Human herpesvirus-6 and the cytokine network in human glial cells

  2005cites this paper
• Expression of gangliosides on glial and neuronal cells in normal and pathological adult human brain.

  2005cites this paper
• Apoptosemarker (sCD95 und DNA-Fragmente) als Aktivitätsparameter bei der Multiplen Sklerose

  2004cites this paper
• Remyelination in multiple sclerosis: a new role for neurotrophins?

  2004cites this paper
• Role of nerve growth factor and other trophic factors in brain inflammation.

  2004cites this paper
• Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease.

  2004cites this paper
• A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis.

  2004cites this paper
• Expression and cellular distribution of high- and low-affinity neurotrophin receptors in malformations of cortical development

  2004cites this paper
• Neurotrophin receptor immunoreactivity in the hippocampus of patients with mesial temporal lobe epilepsy

  2004cites this paper
• [Nerve growth factor and multiple sclerosis: studies on animal models and in humans].

  2004cites this paper
• High-affinity NGF receptor in the rat spinal cord during acute and chronic phases of experimental autoimmune encephalomyelitis: a possible functional significance.

  2003cites this paper
• Basal serum levels and reactivity of nerve growth factor and brain-derived neurotrophic factor to standardized acute exercise in multiple sclerosis and controls.

  2003cites this paper
• Cytokine, chemokine and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuli

  2003cites this paper
• cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity.

  2003cites this paper
• Neurotrophic cross‐talk between the nervous and immune systems: Implications for neurological diseases

  2003cites this paper
• Neurotrophins : brain-derived neurotrophic factor and nerve growth factor

  year unknowncites this paper